KALA earnings: real EPS beat/miss history, analyst consensus Hold, P/E -0.25. Updated 2026-07-23.
KALA BIO (KALA) Research Hub
KALA BIO (KALA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.5724 USD (+2.82%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.25, market cap 0.02B. This hub links to the full technical, earnings and options research available for KALA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.5724 USD (+2.82%) |
| 52-week range | 0.4901 USD – 3.71 USD |
| Trend regime | Range |
| 14-day RSI | 37.8 (Bearish) |
| Trailing P/E | -0.25 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for KALA
Covered Call on KALA: how it works, illustrative setup around the real 0.5724 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on KALA: how it works, illustrative setup around the real 0.5724 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on KALA: how it works, illustrative setup around the real 0.5724 USD price, max profit/loss, breakeven and when to use it. Educational.
KALA technical analysis: range, last 0.5724 USD, RSI 37.8, 52w range 0.4901 USD–3.71 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is KALA in?
KALA BIO (KALA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is KALA in an uptrend or downtrend?
As of 2026-09-11, KALA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is KALA's trailing P/E ratio?
KALA's trailing P/E is -0.25, with a market cap of 0.02B. See the earnings research page for full valuation detail.